Price target
7.170.000.00%
The 1 analyst offering 1 year price forecasts for 214 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 1 analyst giving stock ratings to 214 in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
214 EPS for the last quarter is −0.07 EUR despite the estimation of −0.04 EUR. In the next quarter EPS is expected to reach −0.08 EUR. Track more of ANEBULO PHARMAC. DL-,001 financials and stay on top of what is up with the company.
In the next quarter ANEBULO PHARMAC. DL-,001 revenue is expected to reach 0.00 EUR. Check out ANEBULO PHARMAC. DL-,001 revenue and earnings and make informed decisions.
According to analysts, 214 price target is 7.17 EUR with a max estimate of 7.17 EUR and a min estimate of 7.17 EUR. Check if this forecast comes true in a year, meanwhile watch ANEBULO PHARMAC. DL-,001 stock price chart and keep track of the current situation with 214 news and stock market news.